Showing results (251-260 of 274) with videos related to

Sort By:
Pageof 28
The Journal of Clinical Investigation|June 5, 2018
Neuronatin regulates pancreatic β cell insulin content and secretionSteven J Millership, Gabriela Da Silva Xavier, Agharul I Choudhury, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
GLP-1R associates with VAPB and SPHKAP at ERMCSs to regulate β-cell mitochondrial remodelling and functionGregory Austin, Affiong I Oqua, Liliane El Eid, et al.
The Journal of Clinical Investigation|April 21, 2005
The role of insulin receptor substrate 2 in hypothalamic and beta cell functionAgharul I Choudhury, Helen Heffron, Mark A Smith, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
In vivo functional profiling and structural characterisation of the human Glp1r A316T variantLiliane El Eid, Kieran Deane-Alder, Roxana-Maria Rujan, et al.
Diabetes|January 27, 2011
Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in miceMarc Claret, Mark A Smith, Claude Knauf, et al.
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Extension StudyCori L Daines, Deepika Polineni, Elizabeth Tullis, et al.
Science (New York, N.Y.)|October 3, 2009
Ribosomal protein S6 kinase 1 signaling regulates mammalian life spanColin Selman, Jennifer M A Tullet, Daniela Wieser, et al.
Nature Metabolism|December 5, 2019
Cardiac glycosides are broad-spectrum senolyticsAna Guerrero, Nicolás Herranz, Bin Sun, et al.
The European Respiratory Journal|November 9, 2023
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension studyCori L Daines, Elizabeth Tullis, Stefano Costa, et al.
BMJ Open|August 11, 2019
Testing a support programme for opioid reduction for people with chronic non-malignant pain: the I-WOTCH randomised controlled trial protocolHarbinder K Sandhu, Charles Abraham, Sharisse Alleyne, et al.
Pageof 28